Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,390.00    0.00 (0.00%)
Bid:
2,000.00
Ask:
2,450.00
Spread: 450.00 (22.50%)
Market Cap: £7.67b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

18 Apr 2018 07:00

RNS Number : 2113L
Bunzl PLC
18 April 2018
 

 

18 April 2018

 

BUNZL Q1 TRADING STATEMENT, ACQUISITIONS IN THE US AND

THE NETHERLANDS AND DIRECTORATE CHANGE

 

Bunzl plc, the international distribution and outsourcing Group, today announces its trading statement for the period since 31 December 2017.

 

Overall trading has been consistent with expectations at the time of the annual results announcement at the end of February. Group revenue in the first quarter has increased 7% at actual exchange rates. At constant exchange rates, revenue has risen by 14% compared to the same period last year due to underlying growth of approximately 6% and an impact from acquisitions, net of the disposal of OPM, of approximately 8%. The underlying revenue growth, which is principally due to the additional grocery business won, albeit at lower margins, in North America towards the end of 2016, is expected to return to more normal levels during the remainder of the year as the additional business in North America has now been fully absorbed.

 

The Company also announces that in early March it completed two further acquisitions in the US and the Netherlands.

 

Monte Package Company, which is based in Michigan, is engaged in the distribution of a variety of packaging products to fresh food growers and packers, principally in the eastern US. Revenue in 2017 was US$58 million.

 

Bunzl has also purchased QS Nederland, a provider of hygiene solution services primarily for washrooms with a focus on customers operating in the government, healthcare and foodservice sectors in the Netherlands. Revenue in 2017 was €6 million.

 

Finally the Company today announces that Patrick Larmon, who has been an executive director of the Company and Chief Executive Officer of the Bunzl North America business area since 2004, will be retiring from the Board and the Company with effect from 31 December 2018. He will be succeeded in his role as Chief Executive Officer of Bunzl North America by James McCool. James, who is a qualified accountant and holds a MBA, joined Bunzl in 1998 since when he has held a number of senior management positions in North America, most recently as Chief Financial Officer from 2014 to date and Regional Vice President from 2007 until 2013. He will become Chief Executive Officer Designate of Bunzl North America from 1 May 2018.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive of Bunzl, said:

 

"The purchase of Monte has further enhanced our business in North America serving the agriculture sector while the acquisition of QS complements and extends our existing cleaning & hygiene supplies business in the Netherlands. We are pleased to welcome the employees of both businesses to the Group."

 

Commenting on the retirement of Patrick Larmon, Frank van Zanten said:

 

"I would like to thank Pat for his significant contribution to Bunzl over the last 28 years. In addition to overseeing the successful development of our largest business area, he has also been responsible for building a strong leadership team and developing a robust succession plan. The appointment of Jim, who himself has extensive knowledge and experience of our operations, provides continuity for the business as we look forward to the next stage of its development. Pat will leave the Group with our gratitude and best wishes for the future."

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: +44 (0)20 7353 4200

 

 

Note:

 

The details relating to Patrick Larmon required by Section 430(2B) of the Companies Act 2006 can be found on www.bunzl.com in the Investors section under corporate governance (remuneration).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBXGDSXSBBGIR
Date   Source Headline
21st Jun 20234:54 pmRNSHolding(s) in Company
15th Jun 20237:00 amRNSTrading Statement
8th Jun 20238:00 amRNSAdditional Listing
5th Jun 202311:00 amRNSDirector/PDMR Shareholding
1st Jun 202311:16 amRNSTotal Voting Rights
30th May 20237:00 amRNSAcquisition
24th May 202312:16 pmRNSHolding(s) in Company
18th May 20238:00 amRNSAdditional Listing
3rd May 20234:15 pmRNSDirector/PDMR Shareholding
2nd May 20234:51 pmRNSDirector/PDMR Shareholding
2nd May 202310:37 amRNSDirector/PDMR Shareholding
2nd May 202310:30 amRNSTotal Voting Rights
2nd May 202310:27 amRNSBlock listing Interim Review
27th Apr 20238:00 amRNSAdditional Listing
26th Apr 20234:34 pmRNSResult of AGM
26th Apr 20237:00 amRNSTrading Statement
20th Apr 20238:00 amRNSAdditional Listing
19th Apr 20235:20 pmRNSHolding(s) in Company
13th Apr 20235:06 pmRNSDirector/PDMR Shareholding
12th Apr 20234:43 pmRNSDirector/PDMR Shareholding
11th Apr 20232:10 pmRNSDirector/PDMR Shareholding
11th Apr 20232:10 pmRNSDirector/PDMR Shareholding
11th Apr 202310:25 amRNSDirector/PDMR Shareholding
11th Apr 202310:17 amRNSDirector/PDMR Shareholding
5th Apr 20234:59 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:30 pmRNSTotal Voting Rights
3rd Apr 202310:30 amRNSDirector/PDMR Shareholding
3rd Apr 20239:35 amRNSDirector/PDMR Shareholding
30th Mar 20238:00 amRNSAdditional Listing
28th Mar 202310:58 amRNSDirector/PDMR Shareholding
28th Mar 20239:21 amRNSDirector/PDMR Shareholding
23rd Mar 20238:00 amRNSAdditional Listing
16th Mar 202312:07 pmRNSAnnual Financial Report
16th Mar 20238:00 amRNSAdditional Listing
3rd Mar 20234:56 pmRNSDirector/PDMR Shareholding
2nd Mar 20233:20 pmRNSDirector/PDMR Shareholding
2nd Mar 202312:13 pmRNSDirector/PDMR Shareholding
2nd Mar 202312:09 pmRNSDirector/PDMR Shareholding
1st Mar 20234:31 pmRNSTotal Voting Rights
1st Mar 20234:02 pmRNSDirector/PDMR Shareholding
27th Feb 20232:00 pmRNSDividend Declaration
27th Feb 20237:00 amRNSFinal Results
27th Feb 20237:00 amRNSAcquisition
7th Feb 20237:00 amRNSDirectorate Change
6th Feb 20232:22 pmRNSDirector/PDMR Shareholding
2nd Feb 20237:00 amRNSCUSTOMER CONTRACT
1st Feb 202310:19 amRNSTotal Voting Rights
10th Jan 20233:44 pmRNSDirector/PDMR Shareholding
6th Jan 20234:07 pmRNSDirector/PDMR Shareholding
5th Jan 20235:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.